Injecto Polymers IPO Day 3: GMP ₹0
We’re at the halfway mark for the Injecto Polymers SME IPO, and as we enter Day 3, the subscription figures are looking pretty quiet. It’s still early days, and a lot can change between now and the closing on September 16th, but the current numbers are certainly something to observe. Let’s dive into the details and see what they tell us about investor sentiment.
Subscription Status
As of the end of Day 3, Injecto Polymers has seen zero subscriptions across all categories: Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers). This means not a single share has been applied for yet in any segment. For a company listing on the BSE SME platform, this kind of initial uptake is unusual. Typically, you’d expect to see at least some interest building, especially from retail investors, by the third day. The zero across the board for Retail, NII, and QIB is a bit perplexing. It doesn’t necessarily spell doom, but it does suggest that the market hasn’t yet been captivated by this offering. We’ll be watching closely to see if this changes as we move into the latter half of the IPO period. The lot size of 1200 shares means that a significant chunk of capital is required even for retail investors, which might be a factor, but usually, some initial buzz is generated regardless.
| Category | Subscription | Progress |
|---|---|---|
| Retail | 0.00x | |
| NII / HNI | 0.00x | |
| QIB | 1.57x | |
| Total | 1.57x |
GMP Update
Interestingly, the Grey Market Premium (GMP) for Injecto Polymers remains stagnant at ₹0. It hasn’t budged from yesterday’s figure, and frankly, it hasn’t shown any positive movement since the IPO opened. A GMP of ₹0 suggests that the market isn’t expecting any premium on listing. In fact, it implies that the expected listing price is likely to be around the issue price of ₹100. This lack of a premium in the grey market often correlates with subdued subscription levels. It’s a signal that potential investors aren’t seeing immediate listing gains as a strong incentive to jump in. While GMP is not a definitive indicator, a persistent ₹0 GMP is certainly a point of consideration for anyone looking at this IPO.
Should You Apply?
So, the big question: should you be applying for Injecto Polymers? Based on the current data, it’s a cautious approach that’s warranted. The complete lack of subscriptions by Day 3, coupled with a flat ₹0 GMP, paints a picture of lukewarm investor interest. This isn’t to say the company won’t perform well in the long run, but the initial market reaction isn’t giving us much confidence for listing day gains. Remember, SEBI advisors often recommend looking at a combination of subscription levels, GMP, and the company’s fundamentals. While we haven’t delved into the fundamentals here, the market sentiment, as reflected in subscriptions and GMP, is currently quite muted. If you’re an investor looking for quick listing gains, the current scenario might not be the most appealing. However, if you believe in the long-term prospects of Injecto Polymers and are willing to hold, the current low interest could potentially offer an entry point. Keep an eye on the remaining days; sometimes, a last-minute surge can happen, but don’t bank on it without further positive signals. You can view the full Injecto Polymers IPO details here: View Full Injecto Polymers IPO Details.